Skip to main content
Top
Published in: Tumor Biology 4/2015

01-04-2015 | Research Article

Novel mutations in the RB1 gene from Chinese families with a history of retinoblastoma

Authors: Leilei Zhang, Renbing Jia, Junyang Zhao, Jiayan Fan, YiXiong Zhou, Bing Han, Xin Song, Li Wu, He Zhang, Huaidong Song, Shengfang Ge, Xianqun Fan

Published in: Tumor Biology | Issue 4/2015

Login to get access

Abstract

Retinoblastoma is an aggressive eye cancer that develops during infancy and is divided into two clinical types, sporadic and heritable. RB1 has been identified as the only pathological gene responsible for heritable retinoblastoma. Here, we identified 11 RB1 germline mutations in the Han pedigrees of 17 bilateral retinoblastoma patients from China. Four mutations were nonsense mutations, five were splice site mutations, and two resulted in a frame shift due to an insertion or a deletion. Three of the mutations had not been previously reported, and the p.Q344L mutation occurred in two generations of retinoblastoma patients. We investigated phenotypic–genotypic relationships for the novel mutations and showed that these mutations affected the expression, location, and function of the retinoblastoma protein. Abnormal protein localization was observed after transfection of the mutant genes. In addition, changes in the cell cycle distribution and apoptosis rates were observed when the Saos-2 cell line was transfected with plasmids encoding the mutant RB1 genes. Our findings expand the spectrum of known RB1 mutations and will benefit the investigation of RB1 mutation hotspots. Genetic counseling can be offered to families with heritable RB1 mutations.
Literature
1.
go back to reference Eng C, Li FP, Abramson DH, Ellsworth RM, Wong FL, Goldman MB, et al. Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst. 1993;85(14):1121–8.CrossRefPubMed Eng C, Li FP, Abramson DH, Ellsworth RM, Wong FL, Goldman MB, et al. Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst. 1993;85(14):1121–8.CrossRefPubMed
2.
go back to reference Zucker JM, Desjardins L, Doz F. Retinoblastoma. Eur J Cancer. 1998;34(7):1045–8. discussion 8–9. doi:S0959-8049(98)00181-6.CrossRefPubMed Zucker JM, Desjardins L, Doz F. Retinoblastoma. Eur J Cancer. 1998;34(7):1045–8. discussion 8–9. doi:S0959-8049(98)00181-6.CrossRefPubMed
5.
go back to reference Dryja TP, Rapaport JM, Joyce JM, Petersen RA. Molecular detection of deletions involving band q14 of chromosome 13 in retinoblastomas. Proc Natl Acad Sci U S A. 1986;83(19):7391–4.CrossRefPubMedPubMedCentral Dryja TP, Rapaport JM, Joyce JM, Petersen RA. Molecular detection of deletions involving band q14 of chromosome 13 in retinoblastomas. Proc Natl Acad Sci U S A. 1986;83(19):7391–4.CrossRefPubMedPubMedCentral
6.
go back to reference Zhao J, Dimaras H, Massey C, Xu X, Huang D, Li B, et al. Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis. J Clin Oncol. 2011;29(7):845–51. doi:10.1200/JCO.2010.32.5332.CrossRefPubMed Zhao J, Dimaras H, Massey C, Xu X, Huang D, Li B, et al. Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis. J Clin Oncol. 2011;29(7):845–51. doi:10.​1200/​JCO.​2010.​32.​5332.CrossRefPubMed
7.
go back to reference Toguchida J, McGee TL, Paterson JC, Eagle JR, Tucker S, Yandell DW, et al. Complete genomic sequence of the human retinoblastoma susceptibility gene. Genomics. 1993;17(3):535–43. doi:S0888-7543(83)71368-6.CrossRefPubMed Toguchida J, McGee TL, Paterson JC, Eagle JR, Tucker S, Yandell DW, et al. Complete genomic sequence of the human retinoblastoma susceptibility gene. Genomics. 1993;17(3):535–43. doi:S0888-7543(83)71368-6.CrossRefPubMed
8.
go back to reference Valverde JR. RB1 gene mutation up-date, a meta-analysis based on 932 reported mutations available in a searchable database. 2005 Valverde JR. RB1 gene mutation up-date, a meta-analysis based on 932 reported mutations available in a searchable database. 2005
9.
go back to reference Balmer A, Zografos L, Munier F. Diagnosis and current management of retinoblastoma. Oncogene. 2006;25(38):5341–9. doi:1209622.CrossRefPubMed Balmer A, Zografos L, Munier F. Diagnosis and current management of retinoblastoma. Oncogene. 2006;25(38):5341–9. doi:1209622.CrossRefPubMed
10.
go back to reference Fan JY, Han B, Qiao J, Liu BL, Ji YR, Ge SF, et al. Functional study on a novel missense mutation of the transcription factor FOXL2 causes blepharophimosis-ptosis-epicanthus inversus syndrome (BPES). Mutagenesis. 2011;26(2):283–9. doi:10.1093/mutage/geq086.CrossRefPubMed Fan JY, Han B, Qiao J, Liu BL, Ji YR, Ge SF, et al. Functional study on a novel missense mutation of the transcription factor FOXL2 causes blepharophimosis-ptosis-epicanthus inversus syndrome (BPES). Mutagenesis. 2011;26(2):283–9. doi:10.​1093/​mutage/​geq086.CrossRefPubMed
11.
go back to reference Houdayer C, Dehainault C, Mattler C, Michaux D, Caux-Moncoutier V, Pages-Berhouet S, et al. Evaluation of in silico splice tools for decision-making in molecular diagnosis. Hum Mutat. 2008;29(7):975–82. doi:10.1002/humu.20765.CrossRefPubMed Houdayer C, Dehainault C, Mattler C, Michaux D, Caux-Moncoutier V, Pages-Berhouet S, et al. Evaluation of in silico splice tools for decision-making in molecular diagnosis. Hum Mutat. 2008;29(7):975–82. doi:10.​1002/​humu.​20765.CrossRefPubMed
12.
go back to reference Bertolini S, Cassanelli S, Garuti R, Ghisellini M, Simone ML, Rolleri M, et al. Analysis of LDL receptor gene mutations in Italian patients with homozygous familial hypercholesterolemia. Arterioscler Thromb Vasc Biol. 1999;19(2):408–18.CrossRefPubMed Bertolini S, Cassanelli S, Garuti R, Ghisellini M, Simone ML, Rolleri M, et al. Analysis of LDL receptor gene mutations in Italian patients with homozygous familial hypercholesterolemia. Arterioscler Thromb Vasc Biol. 1999;19(2):408–18.CrossRefPubMed
13.
go back to reference Cowell JK, Smith T, Bia B. Frequent constitutional C to T mutations in CGA-arginine codons in the RB1 gene produce premature stop codons in patients with bilateral (hereditary) retinoblastoma. Eur J Hum Genet. 1994;2(4):281–90.PubMed Cowell JK, Smith T, Bia B. Frequent constitutional C to T mutations in CGA-arginine codons in the RB1 gene produce premature stop codons in patients with bilateral (hereditary) retinoblastoma. Eur J Hum Genet. 1994;2(4):281–90.PubMed
14.
go back to reference Van Orsouw NJ, Li D, van der Vlies P, Scheffer H, Eng C, Buys CH, et al. Mutational scanning of large genes by extensive PCR multiplexing and two-dimensional electrophoresis: application to the RB1 gene. Hum Mol Genet. 1996;5(6):755–61. doi:5w0369.CrossRefPubMed Van Orsouw NJ, Li D, van der Vlies P, Scheffer H, Eng C, Buys CH, et al. Mutational scanning of large genes by extensive PCR multiplexing and two-dimensional electrophoresis: application to the RB1 gene. Hum Mol Genet. 1996;5(6):755–61. doi:5w0369.CrossRefPubMed
15.
go back to reference Blanquet V, Turleau C, Gross-Morand MS, Senamaud-Beaufort C, Doz F, Besmond C. Spectrum of germline mutations in the RB1 gene: a study of 232 patients with hereditary and non hereditary retinoblastoma. Hum Mol Genet. 1995;4(3):383–8.CrossRefPubMed Blanquet V, Turleau C, Gross-Morand MS, Senamaud-Beaufort C, Doz F, Besmond C. Spectrum of germline mutations in the RB1 gene: a study of 232 patients with hereditary and non hereditary retinoblastoma. Hum Mol Genet. 1995;4(3):383–8.CrossRefPubMed
17.
18.
go back to reference Qin XQ, Chittenden T, Livingston DM, Kaelin Jr WG. Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev. 1992;6(6):953–64.CrossRefPubMed Qin XQ, Chittenden T, Livingston DM, Kaelin Jr WG. Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev. 1992;6(6):953–64.CrossRefPubMed
19.
go back to reference Templeton DJ, Park SH, Lanier L, Weinberg RA. Nonfunctional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering. Proc Natl Acad Sci U S A. 1991;88(8):3033–7.CrossRefPubMedPubMedCentral Templeton DJ, Park SH, Lanier L, Weinberg RA. Nonfunctional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering. Proc Natl Acad Sci U S A. 1991;88(8):3033–7.CrossRefPubMedPubMedCentral
20.
go back to reference Yu Y, Alwine JC. Interaction between simian virus 40 large T antigen and insulin receptor substrate 1 is disrupted by the K1 mutation, resulting in the loss of large T antigen-mediated phosphorylation of Akt. J Virol. 2008;82(9):4521–6. doi:JVI.02365-07.CrossRefPubMedPubMedCentral Yu Y, Alwine JC. Interaction between simian virus 40 large T antigen and insulin receptor substrate 1 is disrupted by the K1 mutation, resulting in the loss of large T antigen-mediated phosphorylation of Akt. J Virol. 2008;82(9):4521–6. doi:JVI.02365-07.CrossRefPubMedPubMedCentral
21.
go back to reference Talluri S, Isaac CE, Ahmad M, Henley SA, Francis SM, Martens AL, et al. A G1 checkpoint mediated by the retinoblastoma protein that is dispensable in terminal differentiation but essential for senescence. Mol Cell Biol. 2010;30(4):948–60. doi:10.1128/MCB. 01168-09.CrossRefPubMed Talluri S, Isaac CE, Ahmad M, Henley SA, Francis SM, Martens AL, et al. A G1 checkpoint mediated by the retinoblastoma protein that is dispensable in terminal differentiation but essential for senescence. Mol Cell Biol. 2010;30(4):948–60. doi:10.​1128/​MCB.​ 01168-09.CrossRefPubMed
25.
go back to reference Ali MPV, Honavar S, et al. RB1 gene mutations in retinoblastoma and its clinical correlation. Saudi J Ophthalmol. 2010;2010(24):119–23.CrossRef Ali MPV, Honavar S, et al. RB1 gene mutations in retinoblastoma and its clinical correlation. Saudi J Ophthalmol. 2010;2010(24):119–23.CrossRef
28.
go back to reference Zhang H, Jiao W, Sun L, Fan J, Chen M, Wang H, et al. Intrachromosomal looping is required for activation of endogenous pluripotency genes during reprogramming. Cell Stem Cell. 2013;13(1):30–5. doi:S1934-5909(13)00205-1.CrossRefPubMed Zhang H, Jiao W, Sun L, Fan J, Chen M, Wang H, et al. Intrachromosomal looping is required for activation of endogenous pluripotency genes during reprogramming. Cell Stem Cell. 2013;13(1):30–5. doi:S1934-5909(13)00205-1.CrossRefPubMed
30.
go back to reference Xu K, Rosenwaks Z, Beaverson K, Cholst I, Veeck L, Abramson DH. Preimplantation genetic diagnosis for retinoblastoma: the first reported liveborn. Am J Ophthalmol. 2004;137(1):18–23. doi:S0002939403008729.CrossRefPubMed Xu K, Rosenwaks Z, Beaverson K, Cholst I, Veeck L, Abramson DH. Preimplantation genetic diagnosis for retinoblastoma: the first reported liveborn. Am J Ophthalmol. 2004;137(1):18–23. doi:S0002939403008729.CrossRefPubMed
31.
go back to reference Dommering CJ, Moll AC, Imhof SM, de Die-Smulders CE, Coonen E. Another liveborn after preimplantation genetic diagnosis for retinoblastoma. Am J Ophthalmol. 2004;138(6):1088–9. doi:S0002-9394(04)00936-5.CrossRefPubMed Dommering CJ, Moll AC, Imhof SM, de Die-Smulders CE, Coonen E. Another liveborn after preimplantation genetic diagnosis for retinoblastoma. Am J Ophthalmol. 2004;138(6):1088–9. doi:S0002-9394(04)00936-5.CrossRefPubMed
33.
go back to reference Rechitsky S, Verlinsky O, Chistokhina A, Sharapova T, Ozen S, Masciangelo C, et al. Preimplantation genetic diagnosis for cancer predisposition. Reprod Biomed Online. 2002;5(2):148–55.CrossRefPubMed Rechitsky S, Verlinsky O, Chistokhina A, Sharapova T, Ozen S, Masciangelo C, et al. Preimplantation genetic diagnosis for cancer predisposition. Reprod Biomed Online. 2002;5(2):148–55.CrossRefPubMed
34.
go back to reference Girardet A, Hamamah S, Anahory T, Dechaud H, Sarda P, Hedon B, et al. First preimplantation genetic diagnosis of hereditary retinoblastoma using informative microsatellite markers. Mol Hum Reprod. 2003;9(2):111–6.CrossRefPubMed Girardet A, Hamamah S, Anahory T, Dechaud H, Sarda P, Hedon B, et al. First preimplantation genetic diagnosis of hereditary retinoblastoma using informative microsatellite markers. Mol Hum Reprod. 2003;9(2):111–6.CrossRefPubMed
35.
go back to reference Abou-Sleiman PM, Apessos A, Harper JC, Serhal P, Winston RM, Delhanty JD. First application of preimplantation genetic diagnosis to neurofibromatosis type 2 (NF2). Prenat Diagn. 2002;22(6):519–24. doi:10.1002/pd.393.CrossRefPubMed Abou-Sleiman PM, Apessos A, Harper JC, Serhal P, Winston RM, Delhanty JD. First application of preimplantation genetic diagnosis to neurofibromatosis type 2 (NF2). Prenat Diagn. 2002;22(6):519–24. doi:10.​1002/​pd.​393.CrossRefPubMed
37.
go back to reference Ao A, Wells D, Handyside AH, Winston RM, Delhanty JD. Preimplantation genetic diagnosis of inherited cancer: familial adenomatous polyposis coli. J Assist Reprod Genet. 1998;15(3):140–4.CrossRefPubMedPubMedCentral Ao A, Wells D, Handyside AH, Winston RM, Delhanty JD. Preimplantation genetic diagnosis of inherited cancer: familial adenomatous polyposis coli. J Assist Reprod Genet. 1998;15(3):140–4.CrossRefPubMedPubMedCentral
38.
40.
go back to reference National Retinoblastoma Strategy Canadian Guidelines for Care: Strategie therapeutique du retinoblastome guide clinique canadien. Can J Ophthalmol. 2009;44 Suppl 2:S1-88. doi:10.3129/i09-194 National Retinoblastoma Strategy Canadian Guidelines for Care: Strategie therapeutique du retinoblastome guide clinique canadien. Can J Ophthalmol. 2009;44 Suppl 2:S1-88. doi:10.​3129/​i09-194
41.
go back to reference Richter S, Vandezande K, Chen N, Zhang K, Sutherland J, Anderson J, et al. Sensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastoma. Am J Hum Genet. 2003;72(2):253–69. doi:S0002-9297(07)60537-0.CrossRefPubMed Richter S, Vandezande K, Chen N, Zhang K, Sutherland J, Anderson J, et al. Sensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastoma. Am J Hum Genet. 2003;72(2):253–69. doi:S0002-9297(07)60537-0.CrossRefPubMed
Metadata
Title
Novel mutations in the RB1 gene from Chinese families with a history of retinoblastoma
Authors
Leilei Zhang
Renbing Jia
Junyang Zhao
Jiayan Fan
YiXiong Zhou
Bing Han
Xin Song
Li Wu
He Zhang
Huaidong Song
Shengfang Ge
Xianqun Fan
Publication date
01-04-2015
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 4/2015
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-014-2851-7

Other articles of this Issue 4/2015

Tumor Biology 4/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine